HMGB1 as a therapeutic target for sepsis: It's all in the timing!

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 3, 2014, Pages 243-245

  Gentile, Lori F ^a   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

HMGB1; Sepsis therapeutics

Indexed keywords

ANIMALS; ANTI-INFLAMMATORY AGENTS; HMGB1 PROTEIN; HUMANS; SEPSIS;

EID: 84894223471     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.883380     Document Type: Review

References (17)

1. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192: 565-70
2. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285: 248-51
3. Lamkanfi M, Sarkar A, Vande Walle L, et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 2010;185: 4385-92
4. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004;255: 320-31
5. Yang H, Wang H, Tracey KJ. HMG-1 rediscovered as a cytokine. Shock 2001;15: 247-53
6. Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004;101: 296-301
7. Wang H, Ward MF, Sama AE. Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets 2014;18(3): 257-68
8. Li W, Zhu S, Li J, et al. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxinstimulated macrophages. Biochem Pharmacol 2011;81: 1152-63
9. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012;72: 1491-501
10. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29: 1303-10
11. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011;306: 2594-605
12. Hotchkiss RS, Opal S. Immunotherapy for sepsis - a new approach against an ancient foe. N Engl J Med 2010;363: 87-9
13. Marshall JC, Deitch E, Moldawer LL, et al. Preclinical models of shock and sepsis: what can they tell us? Shock 2005;24(Suppl 1): 1-6
14. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013;110: 3507-12
15. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011;208: 2581-90
16. Davidson GH, Hamlat CA, Rivara FP, et al. Long-term survival of adult trauma patients. JAMA 2011;305: 1001-7
17. Moore LJ, Turner KL, Todd SR, et al. Computerized clinical decision support improves mortality in intra abdominal surgical sepsis. Am J Surg 2010;200: 839-43; discussion 43-4